Old Web
English
Sign In
Acemap
>
authorDetail
>
Douglas E. Bevan
Douglas E. Bevan
Biochemistry
Small molecule
Toll-like receptor
TLR4
Signal transduction
4
Papers
94
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Discovery of Azaindole Ureas as a Novel Class of Bacterial Gyrase B Inhibitors.
2015
Journal of Medicinal Chemistry
Jing Zhang
Qingyi Yang
Jason B. Cross
Jan Antoinette C. Romero
Katherine M. Poutsiaka
Felix Epie
Douglas E. Bevan
Bin Wang
Yanzhi Zhang
Ajit Chavan
Xin Zhang
Terence Moy
Anu Daniel
Kien Nguyen
Brian Chamberlain
Nicole Carter
Joseph Shotwell
Jared Silverman
Chester A. Metcalf
Dominic Ryan
Blaise Lippa
Roland E. Dolle
Show All
Source
Cite
Save
Citations (16)
Discovery of Indazole Derivatives as a Novel Class of Bacterial Gyrase B Inhibitors.
2015
ACS Medicinal Chemistry Letters
Jing Zhang
Qingyi Yang
Jan Antoinette C. Romero
Jason B. Cross
Bin Wang
Katherine M. Poutsiaka
Felix Epie
Douglas E. Bevan
Yuchuan Wu
Terence Moy
Anu Daniel
Brian T. Chamberlain
Nicole Carter
Joseph Shotwell
Anu Arya
Vipul Kumar
Jared Silverman
Kien Nguyen
Chester A. Metcalf
Dominic Ryan
Blaise Lippa
Roland E. Dolle
Show All
Source
Cite
Save
Citations (22)
Development of β-amino alcohol derivatives that inhibit Toll-like receptor 4 mediated inflammatory response as potential antiseptics.
2011
Journal of Medicinal Chemistry
Sherry A. Chavez
Alexander J. Martinko
Corinna Lau
Michael N. Pham
Kui Cheng
Douglas E. Bevan
Tom Eirik Mollnes
Hang Yin
Show All
Source
Cite
Save
Citations (30)
Selection, Preparation, and Evaluation of Small-Molecule Inhibitors of Toll-Like Receptor 4
2010
ACS Medicinal Chemistry Letters
Douglas E. Bevan
Alexander J. Martinko
Lisa C. Loram
Joshua A. Stahl
Frederick R. Taylor
Sampada Joshee
Linda R. Watkins
Hang Yin
Show All
Source
Cite
Save
Citations (26)
1